vision problems semaglutide linked to higher risk of problems, FDA data analysis shows Vision loss with GLP-1s: Wegovy

Consultation Answer a few questions about your symptoms and health history 100% online

Source: Polaris Market Research Analysis Segmental Insights Product Analysis Based on product, the segmentation includes ozempic, Wegovy, Rybelsus, and others

Miller, V

Data Animal Data: In a combined fertility and embryofetal development study in rats, subcutaneous doses of 0.01, 0.03 and 0.09 mg/kg/day (0.2-, 0.7- and 2.1-fold the MRHD) were administered to males for 4 weeks prior to and throughout mating and to females for 2 weeks prior to mating, and throughout organogenesis to Gestation Day 17

This is where having provider support makes all the difference